OKYO Pharma Ltd
NASDAQ:OKYO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
OKYO Pharma Ltd (OKYO) under the Base Case is 0.13 USD per share.
Compared with the current market price of 1.42 USD, the stock appears
Overvalued by 91% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What OKYO Pharma Does
OKYO Pharma Ltd operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. The Company’s principal activity is to develop drugs for inflammatory dry eye diseases and chronic pain by targeting G protein-coupled receptors (GPCRs). The GPCRs is the family of membrane proteins involved in many biological processes. GPCRs is used for the treatment of various conditions, including cardiovascular disease, cancer, and diabetes.
- Headquarters
- United Kingdom UK
- Employees
- 6
- IPO date
- Jul 17, 2018
Earnings Waterfall
OKYO Pharma Ltd
What is the Intrinsic Value of one OKYO stock?
The intrinsic value for OKYO Pharma Ltd (OKYO) under the Base Case is 0.13 USD.
Is OKYO stock undervalued or overvalued?
Compared with the current market price of 1.42 USD, the stock appears Overvalued by 91% .
